Verismo Therapeutics Activates its STAR-101 Clinical Trial to Evaluate Investigational Drug SynKIR-110
Penn spinout Verismo Therapeutics, which focuses on CAR T-cell therapy for solid tumors, has activated its STAR-101 Phase 1 clinical trial at Penn.
PCI’s Carter Caldwell Is Interviewed on Launching a Startup
PCI’s Carter Caldwell, program director for the Penn Medicine Co-Investment Program, discussed his entrepreneurial career and shared advice for others looking to start businesses.
SAFELab takes space at Pennovation Center
SAFELab is a research initiative focused on examining the ways in which youth of color navigate violence on and offline.
Philadelphia Business Journal Features Liz Magill and her Innovation Goals
In an interview about her long-term vision for the university with the Philadelphia Business Journal, Penn President Liz Magill mentions Penn’s breakthroughs in cell and gene therapy.
Philadelphia ranks as one of the top five most active regions for venture capital in 1Q
According to the latest Pitchbook-NVCA Venture Monitor report, the Greater Philadelphia area ranked fifth in the U.S. for the most closed venture capital deals in 2022 and the start of 2023.
REGENXBIO Receives FDA Fast Track Designation for its Novel Gene Therapy Candidate
Penn spinout REGENXBIO received FDA Fast Track designation for its novel gene therapy candidate RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne muscular dystrophy.
PCI Promotes Innovation and Startups at the South by Southwest (SXSW) annual Interactive Conference
It was a great opportunity to share the innovation initiatives coming out of Penn and Philadelphia with a global audience.
Pennovation Accelerator Alumni Develops New Model of 3D Chocolate Printing Press
Ellie Weinstein, Pennovation Accelerator alumni, developed the Cocoa Press to 3D print chocolate.
PACT Enterprise Awards
PCI supported Penn spinouts Interius BioTherapeutics, Verismo Therapeutics, viTToria biotherapeutics, Exyn Technologies, and Avisi Technologies are all nominated for awards.
Nia Therapeutics and Peroxitech Raise Venture Funding
Two Penn spinout companies have recently brought in major investments to help further advance their technologies.